Franklin Resources
GLUE icon

Franklin Resources’s Monte Rosa Therapeutics GLUE Stock Holding History

Franklin Resources’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57M Sell
188,833
-10,889
-5% -$206K ﹤0.01% 1645
2026
Q1 		$3.29M Buy
199,722
+114,491
+134% +$2.19M ﹤0.01% 1712
2025
Q4 		$1.34M Buy
85,231
+41,811
+96% +$563K ﹤0.01% 1962
2025
Q3 		$322K Sell
43,420
-41,068
-49% -$218K ﹤0.01% 2635
2025
Q2 		$381K Buy
84,488
+57,539
+214% +$257K ﹤0.01% 2454
2025
Q1 		$125K Sell
26,949
-561
-2% -$3.44K ﹤0.01% 2789
2024
Q4 		$191K Buy
+27,510
New +$206K ﹤0.01% 2657

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources's GLUE Position: Q2 2026 in Review

Franklin Resources reduced its Monte Rosa Therapeutics (GLUE) stake by 5.5% in Q2 2026, selling an estimated $206K and leaving 188,833 shares worth $4.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Franklin Resources first reported a position in GLUE in Q4 2024 and has held it in 7 quarters since. 193 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Franklin Resources held 188,833 shares of Monte Rosa Therapeutics worth $4.57M as of Q2 2026.
  • Franklin Resources sold 10,889 Monte Rosa Therapeutics shares in Q2 2026, an estimated $206K.
  • Monte Rosa Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1645 holding.
  • Franklin Resources first reported a position in Monte Rosa Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 193 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.